SJS Investment Consulting’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
SJS Investment Consulting's ATRC Position: Q3 2026 in Review
SJS Investment Consulting increased its AtriCure (ATRC) stake by 1.5% in Q3 2026, buying an estimated $90 and bringing the position to 132 shares worth $7.42K. The position accounts for ﹤0.01% of the portfolio, ranked #1506.
SJS Investment Consulting first reported a position in ATRC in Q3 2022 and has held it in 5 quarters since. 283 funds tracked by Wall St. Rank hold ATRC as of Q3 2026.
- SJS Investment Consulting held 132 shares of AtriCure worth $7.42K as of Q3 2026.
- SJS Investment Consulting bought 2 AtriCure shares in Q3 2026, an estimated $90.
- AtriCure made up ﹤0.01% of SJS Investment Consulting's portfolio in Q3 2026, its #1506 holding.
- SJS Investment Consulting first reported a position in AtriCure in Q3 2022 and has held it in 5 quarters since.
- 283 funds tracked by Wall St. Rank held AtriCure as of Q3 2026.
Based on SJS Investment Consulting's 13F filing for Q3 2026, filed 26 Oct 2026.